News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Time is running out to submit your abstract for the EGFR Summit – EGFR Resisters Research Summit
Oct 14, 2024, 18:04

Time is running out to submit your abstract for the EGFR Summit – EGFR Resisters Research Summit

EGFR Resisters Research Summit shared a post on X:

“TIME IS RUNNING OUT to submit your abstract for the EGFR Summit!

Spots Are Filling Up Quickly – Register today.”

Lung Cancer EGFR Summit

 

cancer cancer awareness cancer care EGFR EGFR Resisters Research Summit EGFR Summit fight against cancer Global fight against cancer OncoDaily Oncology
Special Coverage
Science
Jan 18, 2025, 00:00
Five articles suggested by Yüksel Ürün
Blog
Jan 17, 2025, 23:58
Wayne Frederick: The American Cancer Society's Cancer Facts and Figures 2025 report
Blog
Jan 17, 2025, 23:55
David Zaas: Kicking off preparations for the 4th annual Summer Lark event
Blog
Jan 17, 2025, 23:49
The countdown to BGICC 2025 has officially begun - International Cancer Patient Coalition
Blog
Jan 17, 2025, 23:47
From Lab to Clinic: The Power of Mentorship in Cancer Research - Train at NCI
Blog
Jan 17, 2025, 23:44
Lisa A. Lacasse: The American Cancer Society's Cancer Statistics report
Insight
Jan 17, 2025, 22:10
Stephanie Graff: Join me for the upcoming ACS National Breast Cancer Round Table Clinical Trials Webinar
Insight
Jan 17, 2025, 22:08
Darcy Burbage: Celebrating 50 years of excellence in Oncology Nursing Society
Insight
Jan 17, 2025, 22:00
Team Hope returns to Scottsdale - The Hope Foundation for Cancer Research
Blog
Jan 17, 2025, 18:14
Jemma Arakelyan: The Global Clinical Research Governance Conference
Blog
Jan 17, 2025, 18:02
2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents - SPCC
Blog
Jan 17, 2025, 17:53
Intermittent or Continuous FOLFIRI + Panitumumab RAS and BRAF Wild-Type Metastatic CRC